These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 23378772)

  • 81. Anti-prostate cancer effects of CTL cell induction in vitro by recombinant adenovirus mediated PSMA/4-1BBL dendritic cells: an immunotherapy study.
    Sui CG; Wu D; Meng FD; Yang MH; Jiang YH
    Genet Mol Res; 2015 Jun; 14(2):7208-17. PubMed ID: 26125931
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Non-small Cell Lung Cancer Cells Modulate the Development of Human CD1c
    Lu Y; Xu W; Gu Y; Chang X; Wei G; Rong Z; Qin L; Chen X; Zhou F
    Front Immunol; 2019; 10():2829. PubMed ID: 31921114
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Selective colorectal cancer cell lysates enhance the immune function of mature dendritic cells in vitro.
    Chen L; Meng D; Zhao L; Liu R; Bai P; Wang L; Xiao J
    Mol Med Rep; 2015 Mar; 11(3):1877-84. PubMed ID: 25394863
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Expression of a soluble TGF-beta receptor by tumor cells enhances dendritic cell/tumor fusion vaccine efficacy.
    Zhang M; Berndt BE; Chen JJ; Kao JY
    J Immunol; 2008 Sep; 181(5):3690-7. PubMed ID: 18714045
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Restoration of tumor specific human leukocyte antigens class I-restricted cytotoxicity by dendritic cell stimulation of tumor infiltrating lymphocytes in patients with advanced ovarian cancer.
    Santin AD; Bellone S; Palmieri M; Bossini B; Cane' S; Bignotti E; Roman JJ; Cannon MJ; Pecorelli S
    Int J Gynecol Cancer; 2004; 14(1):64-75. PubMed ID: 14764031
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Anti-vascular endothelial growth factor antibody single therapy for pancreatic neuroendocrine carcinoma exhibits a marked tumor growth-inhibitory effect.
    Kasuya K; Nagakawa Y; Suzuki M; Tanaka H; Ohta H; Itoi T; Tsuchida A
    Exp Ther Med; 2011 Nov; 2(6):1047-1052. PubMed ID: 22977618
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Pancreatic-cancer-cell-derived trefoil factor 2 impairs maturation and migration of human monocyte-derived dendritic cells
    Sung GH; Chang H; Lee JY; Song SY; Kim HS
    Anim Cells Syst (Seoul); 2018; 22(6):368-381. PubMed ID: 30533259
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Improved immunogenicity of fusions between ethanol-treated cancer cells and dendritic cells exposed to dual TLR stimulation.
    Koido S; Homma S; Okamoto M; Namiki Y; Kan S; Takakura K; Kajihara M; Uchiyama K; Hara E; Ohkusa T; Gong J; Tajiri H
    Oncoimmunology; 2013 Aug; 2(8):e25375. PubMed ID: 24167764
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Reciprocal Interactions between Fibroblast and Pancreatic Neuroendocrine Tumor Cells: Putative Impact of the Tumor Microenvironment.
    Cuny T; van Koetsveld PM; Mondielli G; Dogan F; de Herder WW; Barlier A; Hofland LJ
    Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884539
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Trial watch: Dendritic cell (DC)-based immunotherapy for cancer.
    Laureano RS; Sprooten J; Vanmeerbeerk I; Borras DM; Govaerts J; Naulaerts S; Berneman ZN; Beuselinck B; Bol KF; Borst J; Coosemans A; Datsi A; Fučíková J; Kinget L; Neyns B; Schreibelt G; Smits E; Sorg RV; Spisek R; Thielemans K; Tuyaerts S; De Vleeschouwer S; de Vries IJM; Xiao Y; Garg AD
    Oncoimmunology; 2022; 11(1):2096363. PubMed ID: 35800158
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma.
    Hugo W; Zaretsky JM; Sun L; Song C; Moreno BH; Hu-Lieskovan S; Berent-Maoz B; Pang J; Chmielowski B; Cherry G; Seja E; Lomeli S; Kong X; Kelley MC; Sosman JA; Johnson DB; Ribas A; Lo RS
    Cell; 2016 Mar; 165(1):35-44. PubMed ID: 26997480
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity.
    Corrales L; Glickman LH; McWhirter SM; Kanne DB; Sivick KE; Katibah GE; Woo SR; Lemmens E; Banda T; Leong JJ; Metchette K; Dubensky TW; Gajewski TF
    Cell Rep; 2015 May; 11(7):1018-30. PubMed ID: 25959818
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Cancer immunotherapy. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells.
    Carreno BM; Magrini V; Becker-Hapak M; Kaabinejadian S; Hundal J; Petti AA; Ly A; Lie WR; Hildebrand WH; Mardis ER; Linette GP
    Science; 2015 May; 348(6236):803-8. PubMed ID: 25837513
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Comparison of cytotoxic T lymphocyte responses against pancreatic cancer induced by dendritic cells transfected with total tumor RNA and fusion hybrided with tumor cell.
    Chen J; Guo XZ; Li HY; Wang D; Shao XD
    Exp Biol Med (Maywood); 2015 Oct; 240(10):1310-8. PubMed ID: 25736302
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Treatment with chemotherapy and dendritic cells pulsed with multiple Wilms' tumor 1 (WT1)-specific MHC class I/II-restricted epitopes for pancreatic cancer.
    Koido S; Homma S; Okamoto M; Takakura K; Mori M; Yoshizaki S; Tsukinaga S; Odahara S; Koyama S; Imazu H; Uchiyama K; Kajihara M; Arakawa H; Misawa T; Toyama Y; Yanagisawa S; Ikegami M; Kan S; Hayashi K; Komita H; Kamata Y; Ito M; Ishidao T; Yusa S; Shimodaira S; Gong J; Sugiyama H; Ohkusa T; Tajiri H
    Clin Cancer Res; 2014 Aug; 20(16):4228-39. PubMed ID: 25056373
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Generation of CTL responses against pancreatic cancer in vitro using dendritic cells co-transfected with MUC4 and survivin RNA.
    Chen J; Guo XZ; Li HY; Liu X; Ren LN; Wang D; Zhao JJ
    Vaccine; 2013 Sep; 31(41):4585-90. PubMed ID: 23928463
    [TBL] [Abstract][Full Text] [Related]  

  • 97. The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting.
    Merad M; Sathe P; Helft J; Miller J; Mortha A
    Annu Rev Immunol; 2013; 31():563-604. PubMed ID: 23516985
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Advances in Human Dendritic Cell-Based Immunotherapy Against Gastrointestinal Cancer.
    Ni L
    Front Immunol; 2022; 13():887189. PubMed ID: 35619702
    [TBL] [Abstract][Full Text] [Related]  

  • 99. What are the molecules involved in regulatory T-cells induction by dendritic cells in cancer?
    Ramos RN; de Moraes CJ; Zelante B; Barbuto JA
    Clin Dev Immunol; 2013; 2013():806025. PubMed ID: 23762097
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Dendritic cells fused with different pancreatic carcinoma cells induce different T-cell responses.
    Andoh Y; Makino N; Yamakawa M
    Onco Targets Ther; 2013; 6():29-40. PubMed ID: 23378772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.